AKT1/PKBalpha Kinase is Frequently Elevated in Human Cancers and Its Constitutive Activation is Required for Oncogenic Transformation in NIH3T3 Cells

Overview

Journal Am J Pathol

Publisher Elsevier

Specialty Pathology

Date 2001 Aug 4

PMID 11485901

Citations 154

Authors

M Sun

G Wang

J E Paciga

R I Feldman

Z Q Yuan

X L Ma

S A Shelley

R Jove

P N Tsichlis

S V Nicosia

J Q Cheng

Affiliations

Soon will be listed here.

Abstract

Extensive studies have demonstrated that the Akt/AKT1 pathway is essential for cell survival and inhibition of apoptosis; however, alterations of Akt/AKT1 in human primary tumors have not been well documented. In this report, significantly increased AKT1 kinase activity was detected in primary carcinomas of prostate (16 of 30), breast (19 of 50), and ovary (11 of 28). The results were confirmed by Western blot and immunohistochemical staining analyses with phospho-Ser473 Akt antibody. The majority of AKT1-activated tumors are high grade and stage III/lV (13 of 16 prostate, 15 of 19 breast, and 8 of 11 ovarian carcinomas). Previous studies showed that wild-type AKT1 was unable to transform NIH3T3 cells. To demonstrate the biological significance of AKT1 activation in human cancer, constitutively activated AKT1 (Myr-Akt) was introduced into NIH3T3 cells. Overexpression of Myr-Akt in the stably transfected cells resulted in malignant phenotype, as determined by growth in soft agar and tumor formation in nude mice. These data indicate that AKT1 kinase, which is frequently activated in human cancer, is a determinant in oncogenesis and a potential target for cancer intervention.

Citing Articles

Novel Mutations in Gene in Prostate Cancer Patients in Jordan.

Alasmar A, Al-Alami Z, Zein S, Al-Smadi A, Al Bashir S, Alorjani M Curr Issues Mol Biol. 2024; 46(9):9856-9866.

PMID: 39329938 PMC: 11430622. DOI: 10.3390/cimb46090586.

The oncogenic fusion protein EML4-NTRK3 requires three salt bridges for stability and biological activity.

Jiang Z, Meyer A, Yang W, Donoghue D Heliyon. 2024; 10(16):e36278.

PMID: 39253179 PMC: 11381775. DOI: 10.1016/j.heliyon.2024.e36278.

Critical domains for NACC2-NTRK2 fusion protein activation.

Yang W, Meyer A, Jiang Z, Jiang X, Donoghue D PLoS One. 2024; 19(6):e0301730.

PMID: 38935636 PMC: 11210774. DOI: 10.1371/journal.pone.0301730.

Inhibition of Prostate Cancer Cell Survival and Proliferation by Carnosic Acid Is Associated with Inhibition of Akt and Activation of AMPK Signaling.

Nadile M, Sze N, Fajardo V, Tsiani E Nutrients. 2024; 16(9).

PMID: 38732504 PMC: 11085396. DOI: 10.3390/nu16091257.

Role of tissue markers associated with tumor microenvironment in the progression and immune suppression of oral squamous cell carcinoma.

Ramalingam S, Shantha S, Muralitharan S, Sudhakar U, Thamizhchelvan H, Parvathi V Med Oncol. 2023; 40(10):303.

PMID: 37731058 DOI: 10.1007/s12032-023-02169-5.

References

Aoki M, Batista O, Bellacosa A, Tsichlis P, Vogt P . The akt kinase: molecular determinants of oncogenicity. Proc Natl Acad Sci U S A. 1998; 95(25):14950-5. PMC: 24556. DOI: 10.1073/pnas.95.25.14950. View

Cheng J, Ruggeri B, Klein W, Sonoda G, Altomare D, Watson D . Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA. Proc Natl Acad Sci U S A. 1996; 93(8):3636-41. PMC: 39663. DOI: 10.1073/pnas.93.8.3636. View

Bellacosa A, Chan T, Ahmed N, Datta K, Malstrom S, Stokoe D . Akt activation by growth factors is a multiple-step process: the role of the PH domain. Oncogene. 1998; 17(3):313-25. DOI: 10.1038/sj.onc.1201947. View

Andjelkovic M, Alessi D, Meier R, Fernandez A, Lamb N, Frech M . Role of translocation in the activation and function of protein kinase B. J Biol Chem. 1998; 272(50):31515-24. DOI: 10.1074/jbc.272.50.31515. View

Datta K, Bellacosa A, Chan T, Tsichlis P . Akt is a direct target of the phosphatidylinositol 3-kinase. Activation by growth factors, v-src and v-Ha-ras, in Sf9 and mammalian cells. J Biol Chem. 1996; 271(48):30835-9. DOI: 10.1074/jbc.271.48.30835. View

Cheng J, Altomare D, Klein M, Lee W, Kruh G, Lissy N . Transforming activity and mitosis-related expression of the AKT2 oncogene: evidence suggesting a link between cell cycle regulation and oncogenesis. Oncogene. 1997; 14(23):2793-801. DOI: 10.1038/sj.onc.1201121. View

Zimmermann S, Moelling K . Phosphorylation and regulation of Raf by Akt (protein kinase B). Science. 1999; 286(5445):1741-4. DOI: 10.1126/science.286.5445.1741. View

Romashkova J, Makarov S . NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling. Nature. 1999; 401(6748):86-90. DOI: 10.1038/43474. View

Franke T, Yang S, Chan T, Datta K, Kazlauskas A, Morrison D . The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell. 1995; 81(5):727-36. DOI: 10.1016/0092-8674(95)90534-0. View

10.

Gioeli D, Mandell J, Petroni G, Frierson Jr H, Weber M . Activation of mitogen-activated protein kinase associated with prostate cancer progression. Cancer Res. 1999; 59(2):279-84. View

11.

Rommel C, Clarke B, Zimmermann S, Nunez L, Rossman R, Reid K . Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt. Science. 1999; 286(5445):1738-41. DOI: 10.1126/science.286.5445.1738. View

12.

Bellacosa A, Testa J, Staal S, Tsichlis P . A retroviral oncogene, akt, encoding a serine-threonine kinase containing an SH2-like region. Science. 1991; 254(5029):274-7. DOI: 10.1126/science.254.5029.274. View

13.

Chan T, Rittenhouse S, Tsichlis P . AKT/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide-dependent phosphorylation. Annu Rev Biochem. 2000; 68:965-1014. DOI: 10.1146/annurev.biochem.68.1.965. View

14.

Jones P, Jakubowicz T, Pitossi F, Maurer F, Hemmings B . Molecular cloning and identification of a serine/threonine protein kinase of the second-messenger subfamily. Proc Natl Acad Sci U S A. 1991; 88(10):4171-5. PMC: 51620. DOI: 10.1073/pnas.88.10.4171. View

15.

Meier R, Alessi D, Cron P, Andjelkovic M, Hemmings B . Mitogenic activation, phosphorylation, and nuclear translocation of protein kinase Bbeta. J Biol Chem. 1997; 272(48):30491-7. DOI: 10.1074/jbc.272.48.30491. View

16.

Ahmed N, Franke T, Bellacosa A, Datta K, Taguchi T, Testa J . The proteins encoded by c-akt and v-akt differ in post-translational modification, subcellular localization and oncogenic potential. Oncogene. 1993; 8(7):1957-63. View

17.

del Peso L, Gonzalez-Garcia M, Page C, Herrera R, Nunez G . Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science. 1997; 278(5338):687-9. DOI: 10.1126/science.278.5338.687. View

18.

Nakatani K, Sakaue H, Thompson D, Weigel R, Roth R . Identification of a human Akt3 (protein kinase B gamma) which contains the regulatory serine phosphorylation site. Biochem Biophys Res Commun. 1999; 257(3):906-10. DOI: 10.1006/bbrc.1999.0559. View

19.

Bellacosa A, De Feo D, Godwin A, BELL D, Cheng J, Altomare D . Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas. Int J Cancer. 1995; 64(4):280-5. DOI: 10.1002/ijc.2910640412. View

20.

Staal S . Molecular cloning of the akt oncogene and its human homologues AKT1 and AKT2: amplification of AKT1 in a primary human gastric adenocarcinoma. Proc Natl Acad Sci U S A. 1987; 84(14):5034-7. PMC: 305241. DOI: 10.1073/pnas.84.14.5034. View